1-, 3-, and 5-Year Survival Rates in Patients with Soft-Tissue Metastasis, Bone Metastasis, or No Metastatic Disease on Their First 68Ga-DOTATATE PET/CT Scan
Survival (%) | No metastasis | Soft-tissue metastasis | Bone metastasis |
1-y | 95.7% | 90.5% | 85.6% |
3-y | 88.6% | 82.3% | 60.5% |
5-y | 81.3% | 71.7% | 44.1% |